Jump to content
IndiaDivine.org

(No subject)

Rate this topic


Guest guest

Recommended Posts

---

The New England Journal of Medicine -- June 24, 1999 -- Vol. 340,

No. 25

Trans Fatty Acids and Coronary Heart Disease

 

--

Trans-unsaturated fatty acids are produced commercially in large

quantities by heating vegetable oils in the presence of metal

catalysts and hydrogen to form shortening and margarine.

 

They are so named because the carbon atoms adjacent to their double

bonds are on opposite sides, resulting in a straight configuration

and a

solid state at room temperature.

 

In contrast, naturally occurring unsaturated fatty acids contain

double

bonds as cis isomers, with

adjacent carbons on the same side of the double bond, resulting in a

bent shape and a liquid state at room temperature.

 

Partial hydrogenation, the process used to create trans fatty acids,

is primarily used to produce solid fats.

 

However, it also removes essential polyunsaturated fatty acids, such

as

linolenic acid and linoleic acid, because they tend to oxidize,

causing the fat to become rancid with prolonged storage or when

exposed to the high temperatures used for commercial deep-fat

frying.

 

Trans fatty acids are also produced in the rumen of cattle,

resulting

in low levels of these isomers in dairy and beef fat.

 

Production of partially hydrogenated fats began early in the 20th

century and increased steadily until about the 1960s, as processed

vegetable fats displaced animal fats in the diets of most people in

industrialized countries.

 

The initial motivation was lower cost, but health benefits were

later

purported.

The average per capita consumption of trans fatty acids from

partially hydrogenated oils has remained at about 2 percent of

calories since the 1960s, because of the increased use of these fats

in commercially baked products and fast foods.

 

By the early 1990s it became apparent that the consumption of trans

fatty acids had uniquely adverse effects on blood lipid levels in

metabolic studies and was associated with an increased risk of

coronary heart disease in epidemiologic investigations.

 

A 1995 industry-sponsored review concluded that there was

insufficient

evidence to take action and that further research was needed. Since

then

many more metabolic and epidemiologic studies have confirmed the

" adverse " effects of trans fatty acids, stimulating the Food and

Drug

Administration to announce plans to include the trans-fatty-acid

content

of foods on product labels.

 

One important issue is whether to list the amount of trans fatty

acids

separately or to combine it with the saturated-fat content. In this

article we shall review the

effects of trans fatty acids on blood lipid levels that have been

identified in metabolic studies and the associated risk of coronary

heart disease that has been identified in epidemiologic studies.

 

 

Metabolic Studies

 

Early metabolic studies generally found that the cholesterol-raising

effect of hydrogenated fat was less than that of saturated fats.

However, the focus on total cholesterol masked the fact that

although

trans fatty acids and saturated fatty acids increase low-density

lipoprotein (LDL) cholesterol levels to a similar degree, trans-

fatty

acids also lower

beneficial high-density lipoprotein (HDL) cholesterol levels as

well.

 

A 1990 study demonstrated that the replacement of a diet high in

" oleic " acid (10 percent of the daily energy intake), the primary

" monounsaturated " fat in diets,

 

with a diet high in trans fatty acids

increased LDL cholesterol levels by 14 mg per deciliter (0.37 mmol

per liter) and decreased HDL cholesterol levels by 7 mg per

deciliter

(0.17 mmol per liter).

 

In contrast, replacement of " oleic " acid with

saturated fatty acids had no effect on HDL cholesterol levels.

 

As a result, the ratio of LDL cholesterol to HDL cholesterol was

significantly higher

with the trans-fatty-acid diet (2.5 than with the saturated-fat

diet (2.34) or the oleic-acid diet (2.02).

 

These findings have been confirmed in many studies, including the

study

by Lichtenstein et al.

reported in this issue of the Journal, with the use of various

levels

and mixtures of trans fatty acids. summarizes the randomized trials

that

directly compared the effects of trans fatty acids with those of

isocaloric amounts of cis fatty acids.

When the data are available,

the figure also shows the effects of saturated fatty acids in the

same studies.

 

Because trans fatty acids increase LDL cholesterol to levels similar

to those produced by saturated fatty acids and also decrease HDL

cholesterol levels, the net effect of trans fatty acids on the ratio

of LDL cholesterol to HDL cholesterol is approximately double that

of

saturated fatty acids.

 

The only somewhat discordant result was from a

small Malaysian study, which found a considerably stronger adverse

effect of trans fatty acids; we have conservatively excluded this

result in estimating the regression line in We also did not include

the study by Almendingen et al. in because they did not compare a

diet high in trans fatty acids with a diet high in oleic acid or

polyunsaturated fat.

 

Almendingen et al. found that trans fatty acids

from hydrogenated fish oil

increased the ratio of LDL cholesterol to HDL cholesterol more than

did butter.

 

The effect of trans fatty acids on the ratio of LDL cholesterol to

HDL cholesterol was significantly larger than that of saturated

fatty

acids in each of the six studies that allowed a direct comparison.

 

Collectively, these studies provide definitive evidence that trans

fatty acids raise this ratio more than do saturated fatty acids.

 

As shown by the best-fit regression line in , an absolute increase

of 2

percent in the intake of trans fatty acids would raise the ratio of

LDL

cholesterol to HDL cholesterol by 0.1 unit.

 

Since a 1-unit increase in the ratio is associated with a 53 percent

increase in the

risk of coronary heart disease, the average intake of 2 percent of

calories from trans fatty acids in the United States would be

predicted

 

to account for a substantial number of deaths from coronary heart

disease.

 

Other trials have compared the effects of butter and margarine on

blood lipid levels. Because margarines are usually higher in cis

fatty acids than butter, the specific effects of trans fatty acids

cannot be estimated accurately from these trials.

 

A meta-analysis of these investigations, however, showed that butter

and stick

margarines, which typically contain 20 to 25 percent trans fatty

acids, have similar effects on the ratio of total cholesterol to HDL

cholesterol. These results confirm the deleterious effects

of trans fatty acids on blood lipid levels and indicate that these

may offset the beneficial effects of polyunsaturated fat.

 

Besides increasing the ratio of LDL cholesterol to HDL cholesterol,

trans fatty acids increase Lp(a) lipoprotein levels when they are

substituted for saturated fatty acids.

A significant increase in Lp

(a) lipoprotein levels was reported in 9 of 10 trials, with an

average increase of 0.5 mg per deciliter per 2 percent of energy

intake from trans fatty acids.

 

High blood levels of Lp(a) lipoprotein have been associated in some

studies with an increased risk of

coronary heart disease; the effect of the smaller variations in

blood

levels of Lp(a) lipoprotein induced by trans fatty acids is

uncertain.

 

Trans fatty acids also raise triglyceride levels measured while

subjects are fasting.

 

Numerous studies have reported increases in

triglyceride levels ranging from 1.0 to 24 mg per deciliter (0.01 to

0.27 mmol per liter), with an average increase of 3.0 mg per

deciliter (0.03 mmol per liter) per 2 percent of energy intake from

trans fatty acids.The effect of such an increase on the risk of

cardiovascular disease, though limited, is probably unfavorable.

 

 

Epidemiologic Studies

 

The strong correlation between the level of intake of saturated

fatty

acids and the rates of coronary heart disease among the 16

populations examined in the Seven Countries Study is often quoted as

evidence that the consumption of saturated fat increases the risk of

coronary heart disease.

 

A subsequent biochemical analysis of food

composites representing the average intake of each cohort at base

line not only confirmed that the intake of saturated fatty acids was

strongly correlated with the risk of death from coronary heart

disease (r=0.88, P<0.001) but also showed that the intake of trans

fatty acids was correlated with the risk of death from coronary

heart

disease (r=0.78, P<0.001).

 

Interpretation of comparisons among

populations with widely different lifestyles is hazardous, but these

data leave room for a potentially substantial effect of trans fatty

acids on the risk of coronary heart disease.

 

Several case-control or cross-sectional studies have also been

conducted. In a case-control study of subjects in the Boston area,

we

found a strong and significant positive association between the

intake of trans fatty acids, assessed with the use of dietary

questionnaires, and the risk of acute myocardial infarction.

 

The relative risk of acute myocardial infarction for the quintile

with

the highest intake of trans fatty acids as compared with the

quintile

with the lowest intake was 2.4 (P for trend <0.001); this

association

was entirely explained by the intake of these fats from hydrogenated

vegetable oil.

 

Bolton-Smith et al. performed a cross-sectional

analysis of the association between the intake of trans fatty acids

and the presence of previously undiagnosed coronary heart disease

among participants in the Scottish Heart Study.

 

The intake of trans

fatty acids was positively correlated with the ratio of LDL plus

very-low-density lipoprotein cholesterol to HDL cholesterol.

 

The odd ratios for coronary heart disease in the quintile with the

highest

intake as compared with the quintile with the lowest intake were

elevated but not significantly so (1.26 in women and 1.08 in men).

 

Studies in which the composition of fatty acids in tissue or plasma

was used as a marker of trans-fatty-acid intake have yielded

conflicting results. With one exception, however, these studies have

been too small to detect an association reliably. The results of the

only large study, which included 671 men with acute myocardial

infarction from eight European countries, were inconclusive. The

overall analyses revealed no association between the intake of trans

fatty acids and the risk of myocardial infarction.

 

However, in contrast to the centers studied in other countries, the

two

centers

studied in Spain, where the rates of coronary heart disease are very

low, reported extremely low levels of trans-fatty-acid intake and

little variation between subjects and thus provided little

information. After the exclusion of these data, the odds ratios for

the third and fourth quartiles of intake, as compared with the

lowest, were 1.53 and 1.44, respectively. The interpretation of the

results of this study has caused controversy, but in any case they

do

not provide strong evidence against the hypothesis that the

consumption of trans fatty acids increases the risk of coronary

heart

disease.

 

The strongest epidemiologic evidence relating dietary factors to the

risk of coronary heart disease has been provided by three large

prospective studies: the Health Professionals Follow-up Study, the

Alpha-Tocopherol Beta-Carotene Cancer Prevention Study, and the

Nurses' Health Study.

 

Those studies assessed the intake of trans fatty acids using

detailed

food-frequency questionnaires whose

results were validated by comparison with the composition of adipose

tissue or food diaries.

 

Each of these studies reported an adverse

effect of trans fatty acids. The relative risk of coronary heart

disease associated with an absolute increase of 2 percent in the

intake of trans fatty acids was 1.36 (95 percent confidence

interval,

1.03 to 1.81) in the Health Professionals Follow-up Study, 1.14 (95

percent confidence interval, 0.96 to 1.35) in the Alpha-Tocopherol

Beta-Carotene Cancer Prevention Study, and 1.93 (95 percent

confidence interval, 1.43 to 2.61) in the Nurses' Health Study. The

higher relative risk in the Nurses' Health Study may have resulted

from the fact that there were four dietary measurements during the

follow-up period, thereby reducing the degree of error in assessing

trans-fatty-acid consumption.

 

In these three cohorts, the relative risks were higher than those

for

saturated-fat consumption. For

example, in the Nurses' Health Study, replacing 5 percent of energy

intake from saturated fat with unsaturated fat was associated with a

42 percent decrease in the risk of coronary heart disease, whereas

replacing 2 percent of energy intake from trans fatty acids with cis

fatty acids was associated with a 53 percent decrease in the risk.

 

These studies have been criticized on the grounds that measurements

of the intake of trans fatty acids were unreliable however, random

errors in measuring the intake would only have led to an

underestimation of the association with the risk of coronary heart

disease.

 

It has also been suggested that the observed associations

resulted from a shift from the use of butter to the use of margarine

among high-risk subjects. If so, the association between the intake

of trans fatty acids and the risk of coronary heart disease should

have been weaker among subjects with stable margarine consumption

and

stronger during the first few years of follow-up. However, in the

Nurses' Health Study,) the exclusion of women who changed their diet

before the beginning of the study strengthened the association.

 

Moreover, consumption of foods high in trans fatty acids such as

cookies, which are hardly perceived as healthy, was also positively

associated with the risk of coronary heart disease.

 

Confounding as a result of unmeasured or poorly measured risk

factors is

a potential problem in any observational study, but these

associations were adjusted for many risk factors related to diet and

lifestyle, and no credible confounding factor has been identified.

 

Adjustment for the intake of dietary fiber attenuated the relation

of

trans-fatty-acid intake to the risk of coronary heart disease in the

Health Professionals Follow-up Study, but not in the other two

studies (and Hu FB: personal communication).

 

Thus, prospective

studies provide consistent evidence that the consumption of trans

fatty acids increases the risk of coronary heart disease.

 

The

observed relative risks of coronary heart disease were larger than

one might predict from the effects of trans fatty acids on LDL and

HDL cholesterol levels alone.

 

The increases in triglyceride and Lp(a)

lipoprotein levels account for only a small increase in risk;

therefore, other mechanisms may be involved.

 

 

Conclusions

Metabolic and epidemiologic studies indicate an adverse effect of

trans fatty acids on the risk of coronary heart disease.

 

Furthermore,

on a per-gram basis, the adverse effect of trans fatty acids appears

to be stronger than that of saturated fatty acids.

 

When ingredients

with no known nutritional benefit are added to foods, a low

threshold

for evidence of harm should be adopted, and it should be the

responsibility of food manufacturers to show that their products are

safe.

 

In Europe, producers have responded rapidly by developing

products free of trans fatty acids that are also low in saturated

fats. These products are also becoming available in the United

States, but heavily hydrogenated stick margarines still retain a

large share of the market.

 

In the United States, only 25 percent to 37 percent of the intake of

trans fatty acids from hydrogenated

vegetable oil comes from margarines;

 

the remainder comes from baked

goods, fried fast foods, and other prepared foods. It is more

difficult to replace trans fatty acids with healthier fats in such

products than in margarines, but the switch could be encouraged by a

change in federal regulations.

 

Current U.S. regulations provide an incentive to manufacturers to

produce foods high in trans fatty acids because food labels are not

required to include the amount of trans fatty acids.

 

Many scientists

agree that the amount of trans fatty acids should be stated on food

labels. One simple option is to combine this information with the

saturated-fat content.

 

This approach, however, ignores the

observation that the intake of trans fatty acids is associated with

a

higher risk of coronary heart disease than is the intake of

saturated

fatty acids.

 

Although changes in labeling are important, they are not enough.

 

Many fast foods contain high levels of trans fatty acids, are exempt

from labeling regulations, and can even be advertised as

cholesterol-free and cooked in vegetable oil.

 

For example, the consumption of one doughnut at breakfast (3.2 g of

trans fatty acids) and a large order

of french fries at lunch (6.8 g of trans fatty acids)

 

adds 10 g of trans fatty acids to one's diet and represents 5

percent of

the total energy intake on an 1800-calorie diet -- and neither

product

needs to be labeled.

 

Five years ago, it became evident that consumption of trans fatty

acids adversely affects blood lipid levels.

 

Subsequent studies have confirmed these metabolic findings and

strengthened epidemiologic

evidence of an important increase in the risk of coronary heart

disease with the consumption of trans fatty acids.

 

These data highlight the need for labeling requirements that include

fast foods.

 

Given the proper incentives, the food industry could replace a large

proportion of the partially hydrogenated fats used in foods and food

preparation with unhydrogenated oils.

 

Such a change would substantially reduce the risk of coronary heart

disease at a moderate

cost, without requiring major efforts focused on education and

behavioral modification.

 

 

Alberto Ascherio, M.D., Dr.P.H.

Harvard School of Public Health

Boston, MA 02115

 

Martijn B. Katan, Ph.D.

Peter L. Zock, Ph.D.

Wageningen Center for Food Sciences

6703 HD Wageningen, the Netherlands

 

Meir J. Stampfer, M.D., Dr.P.H.

Walter C. Willett, M.D., Dr.P.H.

Harvard School of Public Health

Boston, MA 02115

 

Address reprint requests to Dr. Ascherio at the Department of

Nutrition, Harvard School of Public Health, 665 Huntington Ave.,

Boston, MA 02115, or at alberto.-.

 

We are indebted to Jill Arnold for her expert assistance with the

manuscript.

_________________

JoAnn Guest

mrsjoguest

DietaryTipsForHBP

http://www.geocities.com/mrsjoguest/Melanoma.html

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...